Article
The Impact of Genetic Subtypes of Diffuse Large B-Cell Lymphoma for Outcome Prediction and Interpretation of FDG-PET treatment Response Monitoring
2023-10-29
Abstract excerpt
<title>Abstract</title> <p>Next-generation sequencing (NGS)-based genetic subtyping and interim- and end-of-treatment <sup>18</sup>fluorodeoxyglucose-positron emission tomography (i/eot-PET) have high potential for upfront and on-treatment risk assessment to guide personalized treatment of diffuse large B-cell lymphoma (DLBCL-NOS). We performed NGS genetic subtyping according to the Dana Farber Cancer Institute (...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 846321a7-cb2c-5e2d-b05f-f3c391274ba4
- DOI
- 10.21203/rs.3.rs-3480882/v1
